Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Monor – page 61

1 099 clinical trials in Monor, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Monor at a glance
1 099
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 099 trials in Monor

Open in trial search

Giant cell arteritis

Not recruiting

Study on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Embolism venous+1

Not recruiting

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Macitentan
  • Sponsor:Actelion Pharmaceuticals Ltd.

Study Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Exelixis Inc.

Fallopian tube cancer+2

Not recruiting

Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Relacorilant
  • Sponsor:Corcept Therapeutics Inc.

Study on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Bergenbio ASA

Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:Astrazeneca AB

Acute kidney injury

Not recruiting

Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:TIN816
  • Sponsor:Novartis Pharma AG

Neoplasm malignant

Not recruiting

Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Avelumab
  • Sponsor:Pfizer Inc.

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Monor

What the registry says about research in the country

01 Asthma Research

Innovative trials focusing on uncontrolled moderate to severe asthma, evaluating new therapeutic approaches for better disease management. Studies aim to prevent lung function decline and reduce exacerbations.

  • Lung Function Preservation
  • Exacerbation Prevention
  • Maintenance Therapy Enhancement

Research includes evaluation of novel compounds and established treatments as add-on therapies to existing maintenance medications.

02 COPD Management

Comprehensive research into Chronic Obstructive Pulmonary Disease treatments, investigating both triple therapy combinations and novel biological treatments for moderate to severe cases.

  • Triple Therapy Optimization
  • Long-term Safety Studies
  • Exacerbation Reduction

Studies focus on improving cardiopulmonary outcomes and evaluating long-term treatment effectiveness in COPD patients.

03 Respiratory Therapeutics

Advanced clinical research examining innovative respiratory medications and their combinations, with particular attention to treating both asthma and COPD through various delivery systems.

  • Combined Therapy Approaches
  • Inhaler Technology
  • Disease Control Optimization

Investigations include both established treatment combinations and novel therapeutic agents for respiratory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.